Copyright Reports & Markets. All rights reserved.

Global Canine Arthritis Treatment Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now
  • 1.1 Research Scope
  • 1.2 Market Segmentation
  • 1.3 Research Objectives
  • 1.4 Research Methodology
    • 1.4.1 Research Process
    • 1.4.2 Data Triangulation
    • 1.4.3 Research Approach
    • 1.4.4 Base Year
  • 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
    • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.5.2 Covid-19 Impact: Commodity Prices Indices
    • 1.5.3 Covid-19 Impact: Global Major Government Policy
  • 1.6 The Covid-19 Impact on Canine Arthritis Treatment Industry
  • 1.7 COVID-19 Impact: Canine Arthritis Treatment Market Trends

    • 2 Global Canine Arthritis Treatment Quarterly Market Size Analysis

    • 2.1 Canine Arthritis Treatment Business Impact Assessment - COVID-19
      • 2.1.1 Global Canine Arthritis Treatment Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
    • 2.2 Global Canine Arthritis Treatment Quarterly Market Size 2020-2021
    • 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
      • 2.3.1 Drivers
      • 2.3.2 Restraints
      • 2.3.3 Opportunities
      • 2.3.4 Challenges

    3 Quarterly Competitive Assessment, 2020

    • 3.1 By Players, Global Canine Arthritis Treatment Quarterly Market Size, 2019 VS 2020
    • 3.2 By Players, Canine Arthritis Treatment Headquarters and Area Served
    • 3.3 Date of Key Players Enter into Canine Arthritis Treatment Market
    • 3.4 Key Players Canine Arthritis Treatment Product Offered
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Impact of Covid-19 on Canine Arthritis Treatment Segments, By Type

    • 4.1 Introduction
      • 1.4.1 Non-Steroidal Anti-Inflammatory Drugs
      • 1.4.2 Opioids
    • 4.2 By Type, Global Canine Arthritis Treatment Market Size, 2019-2021

    5 Impact of Covid-19 on Canine Arthritis Treatment Segments, By Application

    • 5.1 Overview
      • 5.5.1 Veterinary Hospitals and Clinics
      • 5.5.2 Drug Stores
      • 5.5.3 E-commerce
    • 5.2 By Application, Global Canine Arthritis Treatment Market Size, 2019-2021
      • 5.2.1 By Application, Global Canine Arthritis Treatment Market Size by Application, 2019-2021

    6 Geographic Analysis

    • 6.1 Introduction
    • 6.2 North America
      • 6.2.1 Macroeconomic Indicators of US
      • 6.2.2 US
      • 6.2.3 Canada
    • 6.3 Europe
      • 6.3.1 Macroeconomic Indicators of Europe
      • 6.3.2 Germany
      • 6.3.3 France
      • 6.3.4 UK
      • 6.3.5 Italy
    • 6.4 Asia-Pacific
      • 6.4.1 Macroeconomic Indicators of Asia-Pacific
      • 6.4.2 China
      • 6.4.3 Japan
      • 6.4.4 South Korea
      • 6.4.5 India
      • 6.4.6 ASEAN
    • 6.5 Rest of World
      • 6.5.1 Latin America
      • 6.5.2 Middle East and Africa

    7 Company Profiles

    • 7.1 Elanco (Eli Lilly and Company)
      • 7.1.1 Elanco (Eli Lilly and Company) Business Overview
      • 7.1.2 Elanco (Eli Lilly and Company) Canine Arthritis Treatment Quarterly Revenue, 2020
      • 7.1.3 Elanco (Eli Lilly and Company) Canine Arthritis Treatment Product Introduction
      • 7.1.4 Elanco (Eli Lilly and Company) Response to COVID-19 and Related Developments
    • 7.2 Boehringer Ingelheim
      • 7.2.1 Boehringer Ingelheim Business Overview
      • 7.2.2 Boehringer Ingelheim Canine Arthritis Treatment Quarterly Revenue, 2020
      • 7.2.3 Boehringer Ingelheim Canine Arthritis Treatment Product Introduction
      • 7.2.4 Boehringer Ingelheim Response to COVID-19 and Related Developments
    • 7.3 Zoetis Inc
      • 7.3.1 Zoetis Inc Business Overview
      • 7.3.2 Zoetis Inc Canine Arthritis Treatment Quarterly Revenue, 2020
      • 7.3.3 Zoetis Inc Canine Arthritis Treatment Product Introduction
      • 7.3.4 Zoetis Inc Response to COVID-19 and Related Developments
    • 7.4 Vetoquinol S.A.
      • 7.4.1 Vetoquinol S.A. Business Overview
      • 7.4.2 Vetoquinol S.A. Canine Arthritis Treatment Quarterly Revenue, 2020
      • 7.4.3 Vetoquinol S.A. Canine Arthritis Treatment Product Introduction
      • 7.4.4 Vetoquinol S.A. Response to COVID-19 and Related Developments
    • 7.5 Bayer AG
      • 7.5.1 Bayer AG Business Overview
      • 7.5.2 Bayer AG Canine Arthritis Treatment Quarterly Revenue, 2020
      • 7.5.3 Bayer AG Canine Arthritis Treatment Product Introduction
      • 7.5.4 Bayer AG Response to COVID-19 and Related Developments
    • 7.6 Aratana Therapeutics Inc
      • 7.6.1 Aratana Therapeutics Inc Business Overview
      • 7.6.2 Aratana Therapeutics Inc Canine Arthritis Treatment Quarterly Revenue, 2020
      • 7.6.3 Aratana Therapeutics Inc Canine Arthritis Treatment Product Introduction
      • 7.6.4 Aratana Therapeutics Inc Response to COVID-19 and Related Developments
    • 7.7 Norbrook Laboratories Limited
      • 7.7.1 Norbrook Laboratories Limited Business Overview
      • 7.7.2 Norbrook Laboratories Limited Canine Arthritis Treatment Quarterly Revenue, 2020
      • 7.7.3 Norbrook Laboratories Limited Canine Arthritis Treatment Product Introduction
      • 7.7.4 Norbrook Laboratories Limited Response to COVID-19 and Related Developments
    • 7.8 VetStem Biopharma
      • 7.8.1 VetStem Biopharma Business Overview
      • 7.8.2 VetStem Biopharma Canine Arthritis Treatment Quarterly Revenue, 2020
      • 7.8.3 VetStem Biopharma Canine Arthritis Treatment Product Introduction
      • 7.8.4 VetStem Biopharma Response to COVID-19 and Related Developments
    • 7.9 Dechra Pharmaceuticals Plc
      • 7.9.1 Dechra Pharmaceuticals Plc Business Overview
      • 7.9.2 Dechra Pharmaceuticals Plc Canine Arthritis Treatment Quarterly Revenue, 2020
      • 7.9.3 Dechra Pharmaceuticals Plc Canine Arthritis Treatment Product Introduction
      • 7.9.4 Dechra Pharmaceuticals Plc Response to COVID-19 and Related Developments

    8 Key Findings

      9 Appendix

      • 9.1 About US

      This report covers market size and forecasts of Canine Arthritis Treatment, including the following market information:
      Global Canine Arthritis Treatment Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global Canine Arthritis Treatment Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global Canine Arthritis Treatment Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global Canine Arthritis Treatment Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)

      Key market players
      Major competitors identified in this market include Elanco (Eli Lilly and Company), Boehringer Ingelheim, Zoetis Inc, Vetoquinol S.A., Bayer AG, Aratana Therapeutics Inc, Norbrook Laboratories Limited, VetStem Biopharma, Dechra Pharmaceuticals Plc, etc.

      Based on the Region:
      Asia-Pacific (China, Japan, South Korea, India and ASEAN)
      North America (US and Canada)
      Europe (Germany, France, UK and Italy)
      Rest of World (Latin America, Middle East & Africa)

      Based on the Type:
      Non-Steroidal Anti-Inflammatory Drugs
      Opioids

      Based on the Application:
      Veterinary Hospitals and Clinics
      Drug Stores
      E-commerce

      Buy now